Company Profile
Updated: 17-SEP-09Biogen Idec U.S.Corp.
Private Subsidiary, Headquarters Location
14 Cambridge Ctr., Cambridge, MA 02142-1453, United States
(617)679-2000, (617)679-2617 fax, http://www.biogen.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Biopharmaceutical company principally engaged in discovering and developing drugs for human health care through genetic engineering. Finance: Pharmaceutical licenses and patents.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Antegren's Miss In Crohn's Mars Respectable Earnings For Biogen.
BIOWORLD Today; 11/4/2009; 1311 words; ...second quarter and - with Biogen estimating between $50 million...middle, at $59 million. Biogen reconfirmed its full-year...though, the biggest thing on Biogen's horizon is its pending merger with IDEC Pharmaceuticals Corp., of San
Other News To Note.
BIOWORLD Today; 11/4/2009; 1781 words; ...of James Vincent, Biogen's former CEO and chairman...marketable securities. Biogen attributed the falling...from Serono SA's drug, Rebif. Deltagen...among other things. IDEC Pharmaceuticals Corp., of San Diego...per share. Rituxan U.S. revenues were...
Phase II Patient's Blood Clot Halts IDEC Antibody Trials.
BIOWORLD Today; 11/4/2009; 1177 words; ...Washington Editor IDEC Pharmaceuticals Corp.'s stock dipped Tuesday...monoclonal antibody, IDEC-131, after one...Mass.-based Biogen Inc. stopped Phase...Reardon said. IDEC partnered Zevalin...sales outside the U.S. The worldwide...
FoldRx Kicks Off Phase II/III Against Genetic Neuropathy.
BIOWORLD Today; 11/3/2009; 1162 words; ...after diagnosis. "It's a very dramatic disease...designed to stop FAP's progression by blocking...000 people in the U.S., with the mutation...Genome Therapeutics Corp. (now Oscient Pharmaceuticals...news lately include Biogen Idec Inc., of Cambridge...
Biogen Idec Beats Estimates, Records $773M In Revenues.
BIOWORLD Today; 11/3/2009; 1001 words; ...recognizes product sales. U.S. net sales of Rituxan...sold through partner Elan Corp. plc in the U.S. (based on $46.8 million...As of mid-July, Biogen said, about 13,000 patients...James Mullen, Biogen Idec's CEO, said in a news...
Recent News Articles
- Biogen Idec Extends Offer to Acquire Facet Biotech Corporation for $14.50 Per Share in Cash.
Business Wire - October 16, 2009 - Zacks Analyst Blog Highlights: Elan Corp., Biogen Idec, Johnson & Johnson, LSI Corp. and Adaptec.
Business Wire - September 29, 2009 - Zacks Bull and Bear of the Day Highlights: 3M Company, Genzyme Corp., Biogen Idec, Elan Corp. and Johnson & Johnson.
Business Wire - August 10, 2009 - Zacks Analyst Blog Highlights: Wells Fargo, Bank of America, Acorda Therapeutics, Biogen Idec and Elan Corp.
Business Wire - July 02, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning